Education
About Us
Working with TipRanks
Follow Us
Medico Remedies Ltd. (IN:MEDICO)
:MEDICO
MEDICO Stock Chart & Stats
₹50.16
₹4.58(8.10%)
At close: 4:00 PM EST
₹50.16
₹4.58(8.10%)
Day’s Range― - ―
52-Week Range₹35.00 - ₹65.70
Previous CloseN/A
Volume2.72M
Average Volume (3M)12.74K
Market Cap
₹3.82B
Enterprise Value₹3.94B
Total Cash (Recent Filing)₹25.45M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)32.9
Beta<0.01
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding82,984,000
10 Day Avg. Volume20,955
30 Day Avg. Volume12,740
Financial Highlights & Ratios
PEG Ratio1.99
Price to Book (P/B)7.06
Price to Sales (P/S)2.92
P/FCF Ratio258.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~26.4% revenue growth indicates durable demand and expanding market presence. Over a 2–6 month horizon this trend supports continued scale benefits, better negotiation power with suppliers, and provides structural revenue visibility that underpins reinvestment and strategic planning.
Improving ProfitabilityHealthy gross margin combined with an improving net margin suggests effective cost management and pricing power. This persistent margin improvement is a structural positive for free cash generation and resilience to input-cost swings, supporting durable earnings quality over coming quarters.
Balance Sheet & Cash GenerationA favorable debt profile and positive free cash flow growth indicate financial flexibility and capacity to fund growth or weather downturns. Prudent leverage and strong operating cash conversion provide a durable cushion for capex, working capital, and strategic investments.
Bears Say
Capex Pressure On FCFElevated capital expenditures are materially reducing free cash flow conversion despite positive operating cash flow. If capex remains high, it can constrain discretionary spending, limit deleveraging or dividends, and reduce liquidity flexibility over the medium term.
EBIT Margin VolatilityInstability in EBIT margin points to operating-efficiency volatility that can weaken earnings predictability. Structural margin swings increase execution risk for expansion plans and make long-term profitability more sensitive to cost inflation or pricing pressure.
Reliance On LiabilitiesA moderate reliance on liabilities implies some dependence on external funding. If cash flows slow or financing conditions tighten, this could raise refinancing risk and interest burden, constraining strategic flexibility and increasing vulnerability to macro shifts over 2–6 months.
Medico Remedies Ltd. News
MEDICO FAQ
What was Medico Remedies Ltd.’s price range in the past 12 months?
Medico Remedies Ltd. lowest stock price was ₹35.00 and its highest was ₹65.70 in the past 12 months.
What is Medico Remedies Ltd.’s market cap?
Medico Remedies Ltd.’s market cap is ₹3.82B.
When is Medico Remedies Ltd.’s upcoming earnings report date?
Medico Remedies Ltd.’s upcoming earnings report date is May 30, 2026 which is in 93 days.
How were Medico Remedies Ltd.’s earnings last quarter?
Medico Remedies Ltd. released its earnings results on Feb 12, 2026. The company reported ₹0.346 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.346.
Is Medico Remedies Ltd. overvalued?
According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued.
Does Medico Remedies Ltd. pay dividends?
Medico Remedies Ltd. does not currently pay dividends.
What is Medico Remedies Ltd.’s EPS estimate?
Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medico Remedies Ltd. have?
Medico Remedies Ltd. has 82,984,000 shares outstanding.
What happened to Medico Remedies Ltd.’s price movement after its last earnings report?
Medico Remedies Ltd. reported an EPS of ₹0.346 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.509%.
Which hedge fund is a major shareholder of Medico Remedies Ltd.?
Currently, no hedge funds are holding shares in IN:MEDICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medico Remedies Ltd.
Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.
Technical Analysis
Albert David Ltd
―
Brooks Laboratories Limited
―
Lyka Labs Limited
―
―
Zim Laboratories Ltd.
―